Skip to main content

Day: September 25, 2025

Aya Gold & Silver Categorically Rejects the Erroneous and Misleading Allegations Made Against the Company

MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) strongly refutes the misleading and inaccurate claims contained in the short-seller report. The report contains numerous inaccuracies and mischaracterizations, including about Aya’s current management team, operations, and resource base, which the Corporation believes are intentionally misleading and are intended to benefit the short seller, which has itself disclosed that it stands to profit in the event that the Corporation’s share price declines, at the expense of Aya shareholders. Key Facts Reliability of Resource Model Confirmed by Silver Ounces Mined since 2021Since 2020, Aya has produced over 10 million ounces (“Moz”) of silver (“Ag”), with mined ounces consistently reconciling against the published...

Continue reading

NextGen Digital Platforms Inc. Announces  Approval of Change of Business

Vancouver, B.C., Sept. 25, 2025 (GLOBE NEWSWIRE) — NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) a digital asset and fintech platform bridging traditional capital markets with Web3 infrastructure, is pleased to announce, further to its news release of September 24, 2025, that the proposed expansion of its business into the digital asset ecosystem and the implementation of a cryptocurrency treasury management strategy (the “Change of Business”) has been approved by a majority of the Company’s shareholders by written consent resolutions.  The Company has also received final approval from the Canadian Securities Exchange (the “CSE”) for the Change of Business. In connection with the Change of Business, the Company has filed a CSE Form 2A – Listing Statement dated September 24, 2025 (the...

Continue reading

Lytus Technologies Holdings PTV. Ltd. Announces 1-for-2,500 Reverse Stock Split

Dubai, United Arab Emirates, Sept. 25, 2025 (GLOBE NEWSWIRE) — Lytus Technologies Holdings PTV. Ltd. (OTCQB: LYTHF) (the “Company”), a leader in platform services and next-generation technology, today announced that it intends to effect a reverse stock split of the Company’s common shares at a ratio of 1-for-2,500. The reverse stock split affects all shareholders uniformly and will not alter the relative rights or percentage interest of shareholders in the Company, except as a result of any fractional shares held, as described below. The Company intends for the reverse stock split to become effective and to begin trading on a split-adjusted basis on the OTCQB at the open of trading on September 26, 2025, under the existing trading symbol “LYTHF”. The new CUSIP number for the common shares following the reverse stock split will...

Continue reading

Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly

Palsonify PillsPalsonify pillsPalsonify LogoPalsonify tabletsCrinetics ExteriorCrinetics headquarters in San Diego, CANovel nonpeptide SST2 agonist PALSONIFY advances the treatment paradigm as the first once-daily, oral therapy approved by the FDA to treat acromegaly Approval based on data from two pivotal Phase 3 trials where PALSONIFY was well tolerated and resulted in rapid, durable, and consistent biochemical control and reduced symptom burden Launch of lead product PALSONIFY marks a pivotal milestone for Crinetics as the premier endocrine-focused global pharmaceutical company Investor call to be held today at 6:00 pm ET SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the U.S. Food and Drug Administration (FDA) approved PALSONIFYTM...

Continue reading

EssilorLuxottica: Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States

Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States EssilorLuxottica’s lens is clinically proven to slow myopia progression in children1,2 Paris, France (25 September 2025) – EssilorLuxottica today announced the U.S. Food and Drug Administration (FDA) has granted market authorization for its Essilor Stellest lens using the De Novo pathway. This follows the product’s earlier recognition with the FDA granting designation as a Breakthrough Device in 2021. The Essilor Stellest lens is the first-ever FDA market authorized spectacle lens clinically proven to slow myopia progression in children1,2. The effectiveness of the Essilor Stellest lens is evidenced by clinical data showing that the lens slowed down myopia progression by 71% on average over two years1,2. Leading the global effort to address...

Continue reading

Uniti Group Inc. Announces Pricing of Upsized Senior Notes Offering

Issues Notice of Redemption for Secured Notes due 2028 LITTLE ROCK, Ark., Sept. 25, 2025 (GLOBE NEWSWIRE) — Uniti Group Inc. (the “Company,” “Uniti,” or “we”) (Nasdaq: UNIT) today announced that its subsidiary, Windstream Services, LLC (the “Issuer”), has priced its offering (the “Offering”) of $1.4 billion aggregate principal amount of 7.50% Senior Secured Notes due 2033 (the “Notes”). The offering was upsized by $500.0 million aggregate principal amount compared to the previously announced offering size of $900.0 million. The Notes will be issued at an issue price of 100.00%. The Notes will be guaranteed on a senior unsecured basis by the Company and Uniti Group LLC and on a senior secured basis by each of the Issuer’s subsidiaries that guarantees indebtedness under the Company’s senior secured credit facilities and the Company’s...

Continue reading

G2 Goldfields Closes C$49.5 Million Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 25, 2025 (GLOBE NEWSWIRE) — G2 Goldfields Inc. (“G2” or the “Company”) (TSX:GTWO; OTCQX:GUYGF) is pleased to announce that it has completed the non-brokered private placement announced by the Company on September 11, 2025 (the “Offering”). The Offering consisted of 15,000,000 common shares of the Company (the “Shares”) at a price of C$3.30 per Share, for aggregate gross proceeds of C$49,500,000. The net proceeds from the Offering are expected to be used for continued exploration and development of the Company’s mineral properties in Guyana and for general working capital and general corporate purposes. The Shares have not been and will not be registered under the United States Securities Act of 1933 (the “1933 Act”) and may not...

Continue reading

Verizon to be the first carrier to offer the new AI-powered Meta Ray-Ban Display glasses

Revolutionary AI glasses will be available to Verizon customers, offering a new way to stay connected on the go [Breaking news] BASKING RIDGE, N.J., Sept. 25, 2025 (GLOBE NEWSWIRE) — Verizon announced it will be the first wireless carrier to offer the revolutionary new Meta Ray-Ban Display AI glasses, unveiled last week at Meta’s annual Connect conference. This partnership will bring the next generation of wearable AI technology to Verizon customers, offering a seamless experience on the glasses. The Meta Ray-Ban Display represents a breakthrough in AI glasses, featuring a full-color, high-resolution in-lens display that allows users to stay present in their world while accessing a new suite of AI-powered features. Paired with the innovative Meta Neural Band, the glasses offer intuitive control through subtle hand gestures,...

Continue reading

HF Foods Group Inc. Announces $100 Million At-The-Market (ATM) Equity Offering Program

LAS VEGAS, Sept. 25, 2025 (GLOBE NEWSWIRE) — HF Foods Group Inc. (NASDAQ: HFFG) (“HF Foods” or the “Company”), a leading food distributor to Asian restaurants across the United States, announced today that it has established an At-The-Market (“ATM”) equity offering program under which it may sell, from time to time, shares of its common stock for aggregate gross proceeds of up to $100 million. The shares of common stock will be offered through D.A. Davidson & Co. and Roth Capital Partners, which will serve as sales agents for the ATM. The Company intends to use the net proceeds from the sale of common stock under the ATM primarily for general corporate purposes, which may include, among other things, providing working capital, funding capital expenditures, and paying for possible acquisitions or the expansion of our business. The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.